Waystar Holding Corp. (WAY)

NASDAQ: WAY · Real-Time Price · USD
23.46
+2.03 (9.47%)
At close: Jul 2, 2026, 4:00 PM EDT
23.31
-0.15 (-0.65%)
After-hours: Jul 2, 2026, 7:31 PM EDT
Market Cap4.50B -32.1%
Revenue (ttm)1.16B +18.6%
Net Income126.10M +383.6%
EPS0.67 +338.9%
Shares Out 191.81M
PE Ratio34.87
Forward PE13.98
Dividendn/a
Ex-Dividend Daten/a
Volume6,828,281
Open22.49
Previous Close21.43
Day's Range22.33 - 23.70
52-Week Range17.26 - 41.47
Beta0.07
AnalystsStrong Buy
Price Target33.52 (+42.88%)
Earnings DateJul 29, 2026

About WAY

Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payer payment management, denials prevention and recovery, clinical integrity and revenue capture, and analytics and reporting solutions. It primarily serves healthcare industry. The company was founded in 2017 and is headquartered in Lehi, Utah.

Sector Healthcare
IPO Date Jun 7, 2024
Employees 1,700
Stock Exchange NASDAQ
Ticker Symbol WAY
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 24 analysts, the average rating for WAY stock is "Strong Buy." The 12-month stock price target is $33.52, which is an increase of 42.88% from the latest price.

Price Target
$33.52
(42.88% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Waystar initiated with an Overweight at KeyBanc

KeyBanc initiated coverage of Waystar (WAY) with an Overweight rating and $30 price target The firm sees a “large valuation disconnect” at current share levels given the company’s “high-margin growth…

2 days ago - TheFly

Waystar initiated with an Overweight at KeyBanc

KeyBanc initiated coverage of Waystar (WAY) with an Overweight rating and $30 price target

3 days ago - TheFly

Waystar to Host Investor Day at Waystar True North™ Conference on August 25, 2026

LEHI, Utah and LOUISVILLE, Ky., July 1, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that it will host an Investor Day o...

3 days ago - PRNewsWire

Waystar price target lowered to $34 from $38 at JPMorgan

JPMorgan lowered the firm’s price target on Waystar (WAY) to $34 from $38 and keeps an Overweight rating on the shares. The firm adjusted targets in the health technology space…

9 days ago - TheFly

New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue

Healthcare leaders show unanimous interest in a single AI-powered platform connecting the mid-cycle to the final claim — yet 86% are still leaving revenue on the table LEHI, Utah and LOUISVILLE, Ky., ...

25 days ago - PRNewsWire

Waystar Holding Transcript: 46th Annual William Blair Growth Stock Conference

AI-driven automation is reducing administrative costs and claim denials in healthcare, with rapid adoption leading to strong revenue and EBITDA growth. The platform's proprietary data and deep integration position it for continued expansion and innovation in a growing market.

4 weeks ago - Transcripts

Waystar Holding Slides: 46th Annual William Blair Growth Stock Conference

Waystar Holding has posted slides in relation to its latest quarterly earnings report, which was published on June 2, 2026.

4 weeks ago - Filings

Waystar Holding Transcript: AGM 2026

The meeting covered director elections, auditor ratification, and executive pay vote frequency, with all board recommendations approved by majority. Stockholders could participate virtually and submit questions after business concluded.

4 weeks ago - Transcripts

Waystar to Speak at William Blair Conference

LEHI, Utah and LOUISVILLE, Ky., May 20, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt H...

6 weeks ago - PRNewsWire

Barclays cuts Waystar target, says LBO math ‘increasingly compelling’

Barclays analyst Glen Santangelo lowered the firm’s price target on Waystar (WAY) to $25 from $36 and keeps an Overweight rating on the shares. The firm believes the company’s leveraged…

6 weeks ago - TheFly

3 Best Growth Stocks to Buy This Week, According to Analysts

Growth stocks continue to lead the market as investors look for companies with strong demand and expanding margins. This week, three stocks stand out – Waystar ($WAY), Freshpet ($FRPT), and…

Other symbols: BILIFRPT
6 weeks ago - TipRanks

Waystar rises 7.0%

Waystar (WAY) is up 7.0%, or $1.29 to $19.84.

6 weeks ago - TheFly

Waystar rises 7.7%

Waystar (WAY) is up 7.7%, or $1.42 to $19.97.

6 weeks ago - TheFly

Waystar announces $200M share repurchase program

Waystar (WAY) announced that its Board of Directors authorized a stock repurchase plan for up to $200M of the company’s common stock.

6 weeks ago - TheFly

Waystar Announces $200 Million Share Repurchase Authorization, Reflecting Confidence in Long-Term Outlook

LEHI, Utah and LOUISVILLE, Ky., May 19, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that its Board of Directors authori...

6 weeks ago - PRNewsWire

Waystar Named to TIME100 Most Influential Companies

Wins TIME Impact in AI Award for purpose-built innovation in healthcare LEHI, Utah and LOUISVILLE, Ky., May 5, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment soft...

2 months ago - PRNewsWire

Waystar price target lowered to $30 from $35 at Citi

Citi analyst Daniel Grosslight lowered the firm’s price target on Waystar (WAY) to $30 from $35 and keeps a Buy rating on the shares post the Q1 report. The firm…

2 months ago - TheFly

Waystar price target lowered to $33 from $38 at Goldman Sachs

Goldman Sachs lowered the firm’s price target on Waystar (WAY) to $33 from $38 and keeps a Buy rating on the shares. Vertical and SMID-cap application software trends in Q1…

2 months ago - TheFly

Waystar price target lowered to $38 from $40 at JPMorgan

JPMorgan lowered the firm’s price target on Waystar (WAY) to $38 from $40 and keeps an Overweight rating on the shares.

2 months ago - TheFly

Waystar price target lowered to $32 from $35 at Raymond James

Raymond James analyst Brian Peterson lowered the firm’s price target on Waystar (WAY) to $32 from $35 and keeps a Strong Buy rating on the shares. Waystar reported Q1 results…

2 months ago - TheFly

Waystar price target lowered to $37 from $41 at UBS

UBS analyst Kevin Caliendo lowered the firm’s price target on Waystar (WAY) to $37 from $41 and keeps a Buy rating on the shares. The company delivered solid Q1 results…

2 months ago - TheFly

Waystar reports Q1 adjusted EPS 42c, consensus 39c

Reports Q1 revenue $313.9M, consensus $311.68M. “Waystar (WAY) delivered a solid first quarter, driven by strong execution and continued expansion across our platform,” said Matt Hawkins, Chief Execut...

2 months ago - TheFly

Waystar Holding Earnings Call Transcript: Q1 2026

Q1 2026 saw 22% revenue growth, strong AI-driven bookings, and margin expansion, with provider solutions outpacing patient payments. Guidance for 2026 is reaffirmed, and integration of Iodine and new AI SKUs are driving momentum and expanding the addressable market.

2 months ago - Transcripts

Waystar Holding Earnings release: Q1 2026

Waystar Holding released its Q1 2026 earnings on April 29, 2026, summarizing the period's financial results.

2 months ago - Filings

Waystar Holding Quarterly report: Q1 2026

Waystar Holding has published its Q1 2026 quarterly earnings report on April 29, 2026.

2 months ago - Filings